From July 1, 2022 to December 31, 2022, the company has repurchased 12,078,000 shares, representing 2.94% for HKD 18.44 million. With this, the company has completed the repurchase of 13,412,000 shares, representing 3.28% for HKD 20.54 million under the buyback announced on June 24, 2022.
Lansen Pharmaceutical Holdings Limited
Equities
503
KYG5380M1033
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+33.43% | 700B | |
+27.63% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+16.26% | 236B | |
+6.61% | 202B | |
-9.24% | 197B | |
+4.26% | 161B |